Researcher profile
N.H.B. Schräder
Public evidence
2 connected articles
The C4EB study-Transvamix (10% THC / 5% CBD) to treat chronic pain in epidermolysis bullosa: A protocol for an explorative randomized, placebo controlled, and double blind intervention crossover study.2022 · Europe PMCCannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study.2021 · Europe PMC
Registered research
Connected studies
Matched by exact identifiers only. Profile data: Corpus/OpenAlex.